DELTA-P Score for SVC Syndrome in Tumour
Dutch-English LEMS Tumour Association Prediction (DELTA-P) Score. Predicts prognosis in superior vena cava (SVC) syndrome from lung malignancy and guides treatment decisions.
Score interpretation
→ DELTA-P Low (0–2): Mild SVC syndrome. Can proceed with chemotherapy and/or radiotherapy at own pace; may not require emergency stenting. Elevate head of bed; dexamethasone; multidisciplinary oncology review.
→ DELTA-P Intermediate (3–5): Moderate SVC syndrome. Urgent oncology review; consider endovascular stenting within 24–48 hours; dexamethasone 8 mg BD; avoid central venous access in upper limbs.
→ DELTA-P Severe (≥6): Severe SVC syndrome with risk of airway compromise. Emergency intervention required — endovascular SVC stenting preferred; may require emergency radiotherapy; ICU; anaesthesia/ENT for airway management; dexamethasone IV.
Interpretation bands for the DELTA-P Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Fong Clinical Risk Score for Colorectal Cancer Recurrence · Oncology
- CRASH Score for Chemotherapy Risk Assessment in Elderly Patients · Oncology
- Ann Arbor Staging System for Lymphoma · Oncology
- Rai Staging System for CLL · Oncology
- Follicular Lymphoma International Prognostic Index (FLIPI) · Oncology
- International Staging System for Multiple Myeloma (ISS) · Oncology
- Poractant Alfa (Porcine Surfactant) · Lung Surfactant (Respiratory Distress Syndrome — Neonatal)
- Rasburicase · Tumour Lysis Syndrome
- Osimertinib · Lung Oncology
- Pembrolizumab · Lung Oncology
- Labetalol (IV — Hypertensive Emergency) · Combined Alpha-1 and Beta-Adrenergic Blocker
- Labetalol (IV — Hypertensive Emergency) · Combined alpha and beta blocker
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.